Kim Chi MD, Medical Oncologist, Senior Scientist at the BC Cancer Agency explains what came out of the metastatic castration-sensitive prostate cancer (mCSPC) TITAN study.
Advertisement
By Editor
Kim Chi MD, Medical Oncologist, Senior Scientist at the BC Cancer Agency explains what came out of the metastatic castration-sensitive prostate cancer (mCSPC) TITAN study.